Dainippon Sumitomo wins long-running licensing dispute with Wakunaga
This article was originally published in Scrip
Executive Summary
Dainippon Sumitomo Pharma (DSP) has prevailed in a legal case brought against it by a smaller Japanese company regarding a terminated licensing deal for a quinolone antibacterial.